|
Volumn 12, Issue 3, 2011, Pages 265-266
|
Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. Introduction.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PITAVASTATIN;
QUINOLINE DERIVATIVE;
BLOOD;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL (TOPIC);
EDITORIAL;
HUMAN;
LIFESTYLE;
MULTICENTER STUDY (TOPIC);
PHYSIOLOGY;
RISK FACTOR;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CLINICAL TRIALS AS TOPIC;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIFE STYLE;
MULTICENTER STUDIES AS TOPIC;
QUINOLINES;
RISK FACTORS;
|
EID: 84859731598
PISSN: None
EISSN: 18785050
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (7)
|
References (0)
|